Stocks With Large Value Changes: NetSol Technologies Inc.(NASDAQ:NTWK), Lamperd Less Lethal Inc(OTCMKTS:LLLI), and MultiCell Technologies, Inc.(OTCMKTS:MCET)

Posted by Saimoon August 26, 2014 0 Comment 827 views


New York, NY – 08/26/2014 –  HotStockGains provides investors  and traders with valuable trading strategies via text message and email. To join our free text message alerts service just text the word BREAKOUT to 555888 from your cell phone. Just text STOP to unsubscribe if you ever need to.

NetSol Technologies Inc.(NASDAQ:NTWK) fell forty-seven cents to finish the day at a closing price of $2.96. The 13.7% decrease in value came on a day when the stock also reached a new 52 week low of $2.86. The California-based software products developer has a market capitalization of $31.39 million. Yesterday, a class action lawsuit was filed by Glancy Binkow & Goldberg LLP on behalf of NetSol Technologies Inc.(NASDAQ:NTWK) shareholders, who allege that the company failed to inform them of the delayed release date for its next generation product.

Is It Time To Sell Your NetSol Shares? Take A Look At Our Free NTWK Analysis.

Lamperd Less Lethal Inc(OTCMKTS:LLLI) gained seven cents, a 116.67% increase in value that moved the stock to a new closing price of $0.13. The stock traded for as much as $0.14 during the day, a new 52 week high for the Canada-based civil defense equipment company. Lamperd Less Lethal Inc(OTCMKTS:LLLI) saw its trading volume skyrocket to a figure of 28,452,696 during Monday’s trading, which is significantly higher than its three month average of 603,452.

Why Is Lamperd Less Lethal Receiving High Investor Attention? View Our Free LLLI Analysis.

MultiCell Technologies, Inc.(OTCMKTS:MCET) enjoyed a 57.14% increase in value as the stock rose $0.0004 to finish the day at a new closing price of $0.0011. The stock has a market capitalization of $2.5 million and 3.9 billion tradeable shares. On Monday, MultiCell Technologies, Inc.(OTCMKTS:MCET)announced that it had been issued a patent for its novel drug compositions and platform technologies. The drug would be used to direct the immune system to protect against cancer.

Should You Make A Low-Cost MultiCell Technologies Investment? Click Here For A Free MCET Analysis.

About HotStockGains

I have a confession to make – I am not always right. Sometimes, unfortunately, I will send alerts that experience losses.

I have alerted companies that rallied 100% or even 6,000% (not even joking) in under a week. Likewise, I have alerted companies that tanked 10, 20, sometimes even as much as 30 or 40%. However overall it is about the net result that delivers profits into your portfolio.

Sign up for my free newsletter to receive market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks. If you are not satisfied, simply click unsubscribe.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.


Write Your Comment